Clinical Trial Update: Natural History Study in Patients With LGMDR5/2c

View source ↗

Summary

The natural history study in patients with limb-girdle muscular dystrophy type 2C (gamma-sarcoglycanopathy) sponsored by Atamyo Therapeutics has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Limb-girdle Muscular Dystrophy Type 2c

Snippet

Sponsor: Atamyo Therapeutics | Conditions: Gamma-sarcoglycanopathy | Status: WITHDRAWN